EUVIMEDEUVIMED entdecken
Editorial

Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects

Ingolf Cascorbi iD

Clinical Pharmacology & Therapeutics · 2023

DOI: 10.1002/cpt.3037 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Ingolf Cascorbi. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Cannabinoids, Drug-Related Side Effects and Adverse Reactions, Pharmacology, Pharmacology, Clinical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsDrug-Related Side Effects and Adverse ReactionsPharmacologyPharmacology, ClinicalHumansDrug InteractionsIatrogenic Disease

Substanzen

Cannabinoids

Autor:innen und Institutionen

  • Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.

ORCID-Profile: Ingolf Cascorbi

Zitieren

APA

Cascorbi, I. (2023). Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3037

Vancouver

Cascorbi I. Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.3037

BibTeX
@article{Cascorbi2023,
  author = {Cascorbi, Ingolf},
  title = {Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1002/cpt.3037}
}
Kostenlos starten →